Search results for "Antitumor"

showing 10 items of 520 documents

Triterpenoid saponins from the roots of two Gypsophila species.

2013

Two triterpenoid saponins with two known ones have been isolated from the roots of Gypsophila arrostii var. nebulosa, and two new ones from the roots of Gypsophila bicolor. Their structures were established by extensive NMR and mass spectroscopic techniques as 3-O-β-d-galactopyranosyl-(1→2)-[β-d-xylopyranosyl-(1→3)]-β-d-glucuronopyranosylquillaic acid 28-O-β-d-xylopyranosyl-(1→4)-[β-d-glucopyranosyl-(1→3)]-α-l-rhamnopyranosyl-(1→2)-[β-d-glucopyranosyl-(1→4)]-β-d-fucopyranosyl ester (1), 3-O-β-d-galactopyranosyl-(1→2)-[β-d-xylopyranosyl-(1→3)]-β-d-glucuronopyranosylgypsogenin 28-O-β-d-xylopyranosyl-(1→4)-[β-d-glucopyranosyl-(1→3)]-α-l-rhamnopyranosyl-(1→2)-[β-d-glucopyranosyl-(1→4)]-β-d-fuco…

Gypsophila arrostiiGypsophilaStereochemistryCell SurvivalMolecular ConformationStereoisomerismAntineoplastic AgentsCaryophyllaceaePlant ScienceHorticultureBiochemistryPlant RootsCell LineTerpeneStructure-Activity RelationshipTriterpenoidSpecies SpecificityAnimalsHumansMolecular BiologyCell ProliferationPlant rootsbiologyDose-Response Relationship DrugChemistryStereoisomerismGeneral MedicineSaponinsbiology.organism_classificationTriterpenesRatsHuman colon cancerDrug Screening Assays AntitumorTwo-dimensional nuclear magnetic resonance spectroscopyPhytochemistry
researchProduct

Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models

2010

Oncolytic virotherapy is a potential treatment modality under investigation for various malignancies including malignant brain tumors. Unlike some other natural or modified viruses that show oncolytic activity against cerebral neoplasms, the rodent parvovirus H-1 (H-1PV) is completely apathogenic in humans. H-1PV efficiently kills a number of tumor cells without harm to corresponding normal ones. In this study, the concept of H-1PV-based virotherapy of glioma was tested for rat (RG-2 cell-derived) and for human (U87 cell-derived) gliomas in immunocompetent and immunodeficient rat models, respectively. Large orthotopic rat and human glioma cell-derived tumors were treated with either single …

H-1 parvovirusCancer ResearchPathologymedicine.medical_specialtyParvovirus H-1Secondary infectionAntibodies ViralPolymerase Chain ReactionVirusGliomamedicineAnimalsHumansVirotherapyOncolytic VirotherapybiologyBrain NeoplasmsParvovirusBrainGliomamedicine.diseasebiology.organism_classificationAntibodies NeutralizingMagnetic Resonance ImagingXenograft Model Antitumor AssaysRatsOncolytic virusDisease Models AnimalOncologyViral replicationBasic and Translational InvestigationsDNA ViralNeurology (clinical)Neuro-Oncology
researchProduct

HLA-G and MIC expression in tumors and their role in anti-tumor immunity.

2003

Non-classical MHC class Ib molecules have attracted growing interest in recent years, especially because they interact with non-T-cell inhibitory or triggering receptors expressed on natural killer (NK) and T cells, suggesting that they have a role in immune recognition. Abnormalities in MHC class Ib expression are frequently found in human tumors of various histologies and might be associated with poor clinical outcome despite the local accumulation of immune competent cells. Available data suggest that the balance between activating and suppressing signals significantly influences the efficacy of the immune response and consequently of tumor progression.

HLA-G AntigensMaleAntitumor immunitybiologyImmunologyHistocompatibility Antigens Class IGene ExpressionGenes MHC Class Ichemical and pharmacologic phenomenaInhibitory postsynaptic potentialAcquired immune systemImmune systemTumor progressionHLA AntigensHLA-GNeoplasmsMHC class IImmunologybiology.proteinImmunology and AllergyHumansFemaleReceptorTrends in immunology
researchProduct

Chemotherapy-induced cardiotoxicity: role of the conventional echocardiography and the tissue Doppler.

2011

Aim. The cardiotoxicity of anticancer drugs is an emerging problem and only an identification of the early signs of cardiotoxicity by conventional echocardiography and not (tissue Doppler imaging, TDI), will limit and contain the long-term cardiotoxicity effects. The aim of this study was to identify, through conventional echocardiography and TDI, parameters to use as early "signs" of cardiotoxicity. Methods. A prospective study was performed using patients with breast cancer (72 women, median age 57+/-12) treated with anticancer drugs (adjuvant chemotherapy). All patients underwent a careful cardiological evaluation before starting treatment (T0) and during follow-up at 3 months (T1), 6 mo…

Heart DiseasesBreast NeoplasmsMiddle AgedSettore MED/11 - Malattie Dell'Apparato CardiovascolareEchocardiography DopplerEarly DiagnosisChemotherapy AdjuvantEchocardiographyAntineoplastic Combined Chemotherapy ProtocolsSettore BIO/14 - FarmacologiaHumansFemaleProspective Studiesecocardiogramma doppler tissutale cardiotossicità chemioterapia antitumoraleAgedFollow-Up StudiesMinerva cardioangiologica
researchProduct

Bu2Sn(N-acetyl-L-cysteinate) antitumor activity on HepG2 cells

2010

HepG2 cellantitumor activityorganotin(IV)
researchProduct

Physiological Effects of Hyperthermia

1987

Hyperthermia as a modality for the treatment of malignant tumors, either alone or in combination with radiation or anticancer drugs, is rapidly becoming a clinical reality. Three different mechanisms of action have provided the rationale for considering the use of hyperthermia as an antitumor agent. At moderate hyperthermia (T=40˚ -42.5˚ C), heat can increase cell killing in a synergistic way following exposure of a tumor to ionizing radiation. This radiosensitization is probably based on, among other things, the inhibited repair of radiation-induced DNA lesions. Elevated tissue temperatures at 40˚ -42.5˚ C also sensitize tumor cells to certain chemotherapeutic drugs, particularly to alkyla…

HyperthermiaAntitumor activitybusiness.industryContext (language use)medicine.diseaseBleomycinIonizing radiationchemistry.chemical_compoundCell killingchemistryChemosensitizationmedicineCancer researchChemotherapeutic drugsbusiness
researchProduct

SYNTHESYS AND ANTITUMOR ACTIVITY OF ISOINDOLO [2,1-A]QUINOXALIN-6-IMINES AND THEIR AZA-ANALOGUES

2014

ISOINDOLO [21-A]QUINOXALIN-6-IMINESSYNTHESIS ANTITUMOR ACTIVITY
researchProduct

ISOINDOLO-QUINOXALINE DERIVATIVES HAVING ANTITUMOR ACTIVITY, PROCESS FOR THEIR PRODUCTION AND THEIR USE

2008

New isoindolo[2,1-a]quinoxaline derivatives of general formula (1 ), wherein R represents H or OH and R5 represents H or CN, have been prepared with simple procedures starting from known intermediates and resulted to posses potent in vitro antitumor activity against a panel of about 60 different human tumor cell lines belonging to several kinds of tumors, both hematological and solid. Preparations containing such derivatives as active ingredients are proposed as drugs to be employed in cancer therapy both alone and in combination with other chemotherapeutics.

ISOINDOLO-QUINOXALINE ANTITUMOR ACTIVITYSettore CHIM/08 - Chimica Farmaceutica
researchProduct

Synthesis and antiproliferative activity of triazenoindazoles and triazenopyrazoles: a comparative study.

2003

Several triazenoindazoles and triazenopyrazoles were prepared transforming the appropriate aminoindazoles and aminopyrazoles in the corresponding diazonium salts which were reacted with dimethylamine, diethylamine and pyrrolidine. All the triazenes were tested for their antiproliferative activity against K562, HL60, L1210 and MCF7 cell lines. The biological data showed that the benzocondensation plays a positive role on the antiproliferative activity. The (1)H-NMR spectra showed that the rotational barrier around the N(2)-N(3) bond in the triazene group can be influenced both by the position of this group in the indazole nucleus and by the substitution pattern in the benzene moiety.

IndazolesMagnetic Resonance SpectroscopyHL60StereochemistryAntineoplastic AgentsMedicinal chemistryChemical synthesisPyrrolidinechemistry.chemical_compoundInhibitory Concentration 50Structure-Activity RelationshipDrug DiscoveryTumor Cells CulturedMoietyHumansTriazeneBenzeneDimethylaminePharmacologyDiethylamineIndazoleBicyclic moleculeMolecular StructureOrganic ChemistryGeneral MedicineSettore CHIM/08 - Chimica FarmaceuticachemistryPyrazolesTriazenoindazoles Triazenopyrazoles Antiproliferative activity Hindered rotationDrug Screening Assays AntitumorTriazenesCell DivisionEuropean journal of medicinal chemistry
researchProduct

Novel 4-(3-phenylpropionamido), 4-(2-phenoxyacetamido) and 4-(cinnamamido) substituted benzamides bearing the pyrazole or indazole nucleus: synthesis…

2019

Based on some common structural features of known compounds interfering with p53 pathways and our previously synthesized benzamides, we synthesized new ethyl 5-(4-substituted benzamido)-1-phenyl-1H-pyrazole-4-carboxylates 26a-c, ethyl 5-(4-substituted benzamido)-1-(pyridin-2-yl)-1H-pyrazole-4-carboxylates 27a-c and N-(1H-indazol-6-yl)-4-substituted benzamides 31a,b bearing in the 4 position of the benzamido moiety the 2-phenylpropanamido or 2-phenoxyacetamido or cinnamamido groups. A preliminary test to evaluate the antiproliferative activity against human lung carcinoma H292 cells highlighted how compound 26c showed the best activity. This last was therefore selected for further studies wi…

IndazolesStereochemistryAntineoplastic AgentsApoptosisTRAIL-receptorPyrazole01 natural sciencesBiochemistrychemistry.chemical_compoundDownregulation and upregulationCell Line Tumor2-(3-phenylpropanamido)benzamideDrug DiscoverymedicineHumansMoietyMolecular BiologyCell ProliferationBiological evaluationP53Indazole010405 organic chemistryDrug Discovery3003 Pharmaceutical Science2-cinnamamidobenzamideOrganic ChemistryApoptosi2-(2-phenoxyacetamido)benzamide0104 chemical sciences010404 medicinal & biomolecular chemistrymedicine.anatomical_structureProto-Oncogene Proteins c-bcl-2Mechanism of actionchemistryApoptosisBenzamidesPyrazolesDrug Screening Assays Antitumormedicine.symptomNucleusBioorganic Chemistry
researchProduct